🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The prognosis for older individuals with acute myelogenous leukemia (AML) h...
Status
Completed
Location
University of Michigan Cancer Center
Start Date
2007-03
Trial ID
NCT00623935
Treatments Being Tested
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
A Dose Finding Study of \[177Lu\]Lu-DOTA-TATE in Newly Diagnosed Glioblasto...
Status
Active Not Recruiting
Location
Col Uni Med Center New York Presby
Start Date
2022-05-10
Trial ID
NCT05109728
Treatments Being Tested
RATIONALE: Giving low doses of chemotherapy, such as fludarabine, and total...
Status
Terminated
Location
OHSU Knight Cancer Institute
Start Date
2003-05
Trial ID
NCT00416884
Treatments Being Tested
This study is being done to test a transplant method that may have fewer si...
Status
Suspended
Location
St. Jude Children's Research Hospital
Start Date
2020-04-30
Trial ID
NCT04362293
This is a randomized, controlled clinical trial based on prior exploratory ...
Status
Not Yet Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2027-01-01
Trial ID
NCT07686796
Treatments Being Tested
RATIONALE: Giving chemotherapy drugs, such as fludarabine and cyclophospham...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2005-07-28
Trial ID
NCT00309842
This is a prospective observational cohort study of haploidentical transpla...
Status
Unknown
Location
Instituto Nacional de Cancer
Start Date
2016-04
Trial ID
NCT02759822
Treatments Being Tested
This is a Phase II trial to determine the efficacy and safety of stereotact...
Status
Completed
Location
Houston Methodist Cancer Center
Start Date
2017-07-01
Trial ID
NCT03004183
Treatments Being Tested
This is a Phase II study following subjects proceeding with our Institution...
Status
Recruiting
Location
Masonic Cancer Center at University of Minnesota
Start Date
2023-05-01
Trial ID
NCT05805605